Experts from the University of Leeds and Leeds Teaching Hospitals NHS Trust are in line to receive £3.5 million to pioneer new radiotherapy technologies, which will include the use of artificial intelligence and imaging technology.
Cancer Research UK has made the funds available over the next five years as part of a UK-wide network known as RadNet, with just seven Centres of Excellence set up to pursue these avenues. As well as the base in Leeds, sites will be located in Cambridge, Manchester, London, Glasgow and Oxford.
Research at the Leeds Centre of Excellence will combine the use of magnetic resonance imaging, artificial intelligence and new drugs with radiotherapy, focusing on those with brain, liver, prostate, rectal and anal cancers.
“Using artificial intelligence analysis of the MRI scans will help us to tailor future treatment for patients and reduce side effects, resulting in new, precise and personalised treatments – and a better quality of life afterwards – in the next five to ten years,” the School of Medicine’s professor David Sebag-Montefiore said.
He went on to say that the Cancer Research UK funding will also help to create 13 new researcher posts and strengthen the city’s position as one of the best destinations to train.
Further research from the University of Leeds recently discovered that vitamin D can help to make melanoma cells less aggressive. The team found that it could influence the behaviours of signalling pathways in melanoma cells in mice, slowing their growth and stopping them from spreading to the lungs.
For help with scientific professionals recruitment, get in touch with us today.